Abacavir acetate

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameAbacavir acetate
Drug Alias Name阿巴卡韦PrurisolKM-133
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionReverse transcriptase inhibitors
TargetsReverse transcriptase
Therapy Area/IndicationsPlaque psoriasisAcidosis, LacticPsoriasis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUganda +[9] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCellceutix Pharma
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of EdinburghJanssen Research & Development Llc
Inactive CompaniesGlaxosmithkline PlcGilead Sciences IncInnovation Pharmaceuticals Inc +[6] 
Active IndicationsAicardi SyndromeHIV Infections
Inactive IndicationsPlaque psoriasisAcidosis, LacticPsoriasis +[4] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank